• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Prevention best measure with post-inflammatory hyperpigmentation

Article

New York - Dermatologists need to be particularly vigilant for post-inflammatory hyperpigmentation when treating patients of African descent or any other darker-skinned patient for dermatologic conditions that have an inflammatory component, Susan C. Taylor, M.D., said at the annual meetinig of The Skin of Color Center, St. Luke's-Roosevelt Hospital Center.

Related Videos
Related Content
Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine

Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine

Article
ReV Up Your Vitiligo Treatment Strategies

ReV Up Your Vitiligo Treatment Strategies

Podcast
Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment and Stigmatization

Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment and Stigmatization

Article
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma

Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma

Article
© 2024 MJH Life Sciences

All rights reserved.